Bionomics Limited (OTCQX: BNOEF)

Описание: Dr. Deborah Rathjen, CEO & Managing Director of Bionomics Limited, talks about how they harness innovation to enhance the drug pipeline, and their recent R&D collaboration for the treatment of cognitive dysfunction in Alzheimer’s patients.

Bionomics is a global, clinical stage biopharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of best in class novel drug candidates focused on the treatment of serious central nervous system disorders and on the treatment of cancer.

To know more about Bionomics, go to http://bit.ly/OTCQX-BNOEF.